We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cindy Powell who wrote (156)6/11/1998 4:15:00 PM
From: (no name provided)  Read Replies (1) of 196
Hey Cindy

Thougth you'd appreciate this update: spoke with a real talker at Advanced Biotechnologies about MDI and the new JV Regenere:
1. ABT has some really hot scar reduction product called Kelo-Cote
they even have a super web site: (check it out)
which is a silicon gel which when applied to an older scar will actually reduce the scar's thickness, height and overall appearance.(also they have a whole new line of "cosmecuticals" which they've been developing with {you guessed it} MLSC! one of these new products actually reduces the appearance of stretch marks and wrinkles). ABT even has patents on all of this!
2. MDI has developed some revolutionary products based on all of those patents they've been collecting over the years which are useful in skin and wound care (something to do with MDI's Japanese R&D group)
3. The new JV is called Regenere (means to revitalize-French-Kulas' wife is from Paris and worked in the cosmetics industry-) this new line of "cosmeceuticals" is based on ABT/MDI technologies and MDI/ABT clinical science...they even have a new marketing person joining them from Paris to launch Regenere's marketing/advertising campaign!
4. Regenere already has distribution contracts in place, and is signing more...targets are: plastic surgeons/hospitals/dermatologists
and Cosmetics industry: skin care/scar reduction etc.
5. The reason for all the activity is to create companies (Regenere), divisions (MDI Health care systems), strategic alliances (ABT/MDI) and other Joint Ventures which will allow MDI and ABT to maximize their technologies for the "consumer" markets, so both MDI and ABT can individually (but with some mutual collaboration) pursue FDA approvals for their "core technologies" (MLSC: HIV/AIDS drug, Blood Decontamination/Sterilization, medical/dental sterilizer, anti-bacterial agents etc; ABT: "implants")
6. Both MDI CEO (Kulas) and ABT CEO (Berlat) are friends and share same philosophies...innovation, scientific validation, strategic alliance approach to business
7. MDI brings technology, patents, world-class institutional relationships, strong R&D (USA/Japan), products...
8. ABT brings technology, patents, products, clean room manufacturing, R&D

When you add it all up seems likes Regenere should be a winner, with the biggest winners of all MLSC and ABT

Bye for now...

"Private Eyes"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext